- Home
- COLD vs XENE Comparison
COLD vs XENE Comparison
Compare COLD & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COLD | XENE |
|---|---|---|
| Founded | 1903 | 1996 |
| Country | United States | Canada |
| Employees | 12690 | 370 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 5.3B |
| IPO Year | 2009 | 2014 |
Fundamental Metrics
Financial Performance| Metric | COLD | XENE |
|---|---|---|
| Price | $12.08 | $55.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 11 |
| Target Price | $14.97 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 3.2M | 767.8K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 7.38% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,601,846,000.00 | $311,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.86 | $2,496.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.10 | $28.19 |
| 52 Week High | $19.81 | $62.91 |
Technical Indicators
Market Signals| Indicator | COLD | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 48.58 | 49.10 |
| Support Level | $11.98 | $52.55 |
| Resistance Level | $12.24 | $56.66 |
| Average True Range (ATR) | 0.42 | 1.83 |
| MACD | 0.00 | -0.72 |
| Stochastic Oscillator | 16.97 | 32.29 |
Price Performance
Historical ComparisonAbout COLD Americold Realty Trust Inc.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 231 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.